MRNX (Defiance Daily Target 2X Long MRNA ETF) Stock Analysis - Financials

Defiance Daily Target 2X Long MRNA ETF (MRNX) is a publicly traded the market company. As of May 21, 2026, MRNX trades at $27.10 with a market cap of $0 and a P/E ratio of 0.00. MRNX moved -3.43% today. Year to date, MRNX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are MRNX's key financials?

MRNX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MRNX recently traded at $27.10. Market cap is $0. P/E ratio is 0.00. Revenue is $0.

MRNX Key Metrics

Key financial metrics for MRNX
MetricValue
Price$27.10
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume171.29K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest MRNX News

MRNX Analyst Consensus

MRNX analyst coverage data. Average price target: $0.00.

Common questions about MRNX

What are MRNX's key financials?
MRNX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MRNX recently traded at $27.10. Market cap is $0. P/E ratio is 0.00. Revenue is $0.
Is MRNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRNX. It does not provide personalized investment advice.
MRNX

MRNX